Past Events

5th ACRP Israeli National Conference

From Helsinki to Israel – in which direction are the Israeli ethics committees turning?
On January 10th, 2010, the Israeli Chapter of ACRP hosted its 5th annual National Conference in Ben-Gurion airport city, Israel, with the support of Pharma Israel, Israel Life Science Industry (ILSI), and the Israel Medical Association (IMA).

• The ACRP-Israeli chapter:  the Association of Clinical Research Professionals (ACRP) is a global professional organization comprised of more than 18,000 individuals dedicated to clinical research and development. The aim of the Association is to provide global leadership for the clinical research profession by promoting and advancing the highest ethical standards and practices. ACRP acts through local chapters, including Israel.

• Pharma-Israel: the association of the Israeli subsidiaries of the multinational companies, leaders in medical research & Development. Pharma Israel aspires to create an environment that attracts multinational pharmaceutical companies to invest in the research and development of innovative medicines in Israel, while ensuring the safety of medications and their and accessibility to the public.
  
• ILSI: a non-profit registered corporation, representing the mutual goals of the Israeli life science community
  
• Israeli Medical Association (IMA):

The conference dealt with the involvement of the IRBs and the MOH boards in the clinical studies submission, approval and follow-up processes. We have characterized the current situation, identified areas for improvement and raised suggestions how to improve the current processes. This will was done by panel discussions with representatives of all involved parties: IRBs, MOH, investigators, and the sponsor companies.
The organizing committee thanks the lecturers, the panelists and the conference attendees.

Attached please find the presentation of:

• Ms. Daniela Karrer about "ECs in EU and IRBs in US – what has changed in recent years?"
• Dr. Mina Arinos about "Clinical Studies’ approvals by the Israeli MOH – what is the decision making process?"

>> ECs in EU and IRBs in US (pdf)
>> Clinical Studies approvals by the Israeli MOH (pdf)
>> 5th Israeli National Conference Agenda

4th ACRP Israeli National Conference

Proposed Israeli Law for Clinical Trial Conduct in Human Subjects – balances or limitations?
On September 10th, 2008, the Israeli Chapter of ACRP hosted its 4th annual National Conference in Tel Aviv, Israel, with the support of Pharma Israel, Israel Life Science Industry (ILSI), and the Israel Medical Association (IMA). The conference was attended by close to 300 clinicians, scientists, lawyers, clinical research associates and coordinators, members and chairpersons of local IRBs, and representatives of the pharmaceutical industry. The event was chaired by the President of the ACRP Israeli Chapter, Ahuva Koren.

In addition to the two main presentations at the conference, which can be found below, there were two panel discussions on “Balances and limitations in the proposed law, the fundamental aspect” and “practical aspects of the proposed law.” Additional information on the conference and these panel discussions can be found in the Report below.

Two central messages were delivered during the conference: 1)The local clinical trials industry and medical center based research units strongly recommend that the legislation will define clear timelines for the approval process for clinical trials in Israel. 2) Industry and hospital based clinical investigators endorse the initiation of a national campaign via the media to promote volunteer participation in clinical trials.
 It was concluded that clinical research is a win-win-win situation, with medical, clinical and legitimate economic benefits for participants, clinicians and the pharmaceutical industry.  The 4th Conference of the Israeli Chapter of ACRP provided an essential platform for discussion concerning the promotion of the proposed Israeli law for clinical trial conduct in human subjects. Attendees had the opportunity to voice their views which were heard by the legislators and will undoubtedly impact final legislation.

>> Present Status of the Israeli Law (pdf)
>> Status of Israeli Clinical Research (pdf)
>> 4th Israeli National Conference Report

3rd Israeli National Conference

Medical Devices Research & Development; How to Navigate the Global and Local Challenges?

On May 29th, 2006 the 3rd annual Israeli National Conference took place in conjunction with the BioMed 2006 Conference and Exhibition (www.kenes.com/biomed) to which the entire Israeli Life Sciences Industry was invited. The chosen theme of the conference "Medical Devices Research & Development; How to navigate the global and local challenges?" explored the unique set of challenges that each medical device researcher must address to be successful in a global environment. The presentations at the conference were given by leading representatives from the Ministry of Health, key people from the local pharmaceutical and R&D industries, as well as by lecturers from abroad.

2nd Annual Conference of the ACRP-Israeli Chapter

On 27 June, 2005, 300 Israeli members of the local ACRP chapter met at Dan-Panorama hotel in Tel Aviv for the 2nd Annual Conference. Ahuva Koren the chair of the Israeli chapter and CEO of GCP Clinical Studies Company that collaborates for the last 3 yrs with the global Association for Clinical Research Professionals (ACRP) in the training and education arena for clinical research professionals in Israel, welcomed the attendees and opened the event.

The theme of the conference was "Ethics in Clinical Studies; Restriction or Protection?" and sessions revolved around the ethical dilemmas that, sponsors, investigators, Ethics Committees, and other related professionals, are facing in the daily conduction of clinical studies. For more information about this event, as well as pictures from the conference, please follow this link.